Treatment Options Reviewed for Herpes Simplex Viral Keratitis

This article originally appeared here.
Share this content:
Treatment Options Reviewed for Herpes Simplex Viral Keratitis
Treatment Options Reviewed for Herpes Simplex Viral Keratitis

TUESDAY, June 14, 2016 (HealthDay News) -- There is a need for development of new anti-herpetic compounds with different mechanisms of action for herpes simplex viral keratitis (HSVK), according to a review published online June 6 in Clinical & Experimental Ophthalmology.

Noting that HSVK is an important cause of visual impairment, Michael Tsatsos, M.D., Ph.D., from the Dorset County Hospital NHS Foundation Trust in Dorchester, U.K., and colleagues reviewed the evidence on the pathogenesis of different HSVK disease modalities.

The researchers note that current therapeutic practice is based on outcomes from the Herpetic Eye Disease Studies I and II, which examined the effectiveness of oral acyclovir in management of stromal herpes keratitis. Newer medications such as valacyclovir may have a superior therapeutic effect to acyclovir; the reduced dosage may aid compliance, and increased bioavailability could increase efficacy. With the increased incidence of acyclovir-resistant infections, there is a need to develop new anti-herpetic compounds with different mechanisms of action, which will be safe and effective against viral strains that are drug resistant; antiviral agents such as foscarnet and cidofovir may be used. Topical ganciclovir is a front-line topical antiviral drug which exhibits less toxicity and offers a simpler dosing regimen.

"Furthering the understanding of herpetic eye disease and promoting the development of more targeted therapy will undoubtedly alter our practice in the future and reduce the significant disease burden associated with this condition," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters


More in Home

Triple Therapy Tied to Reduced Rate of COPD Exacerbations

Triple Therapy Tied to Reduced Rate of COPD ...

Benefits seen for triple therapy with fluticasone furoate, umeclidinium, and vilanterol

Marital Status Tied to Earlier Presentation of Melanoma

Marital Status Tied to Earlier Presentation of Melanoma

Being married also tied to likelihood of undergoing SLNB in lesions with Breslow thickness >1 mm

Mild TBI May Increase Risk of Parkinson's Disease

Mild TBI May Increase Risk of Parkinson's Disease

In adjusted analyses, increased risk seen for all-severity TBI, mild TBI, moderate-severe TBI

is free, fast, and customized just for you!

Already a member?

Sign In Now »